[
  {
    "dateAnnounced":"5/28/2009",
    "currency":"$",
    "headline":"1161",
    "upfront":"140",
    "ms":"MS+RoS",
    "equityStake":"No",
    "acquired":"Exelis Inc",
    "acquiror":"Sanofi",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"PI/II",
    "comment":"Research collaboration (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"10/27/2009",
    "currency":"$",
    "headline":"765",
    "upfront":"110",
    "ms":"MS+RoS",
    "equityStake":"No",
    "acquired":"Medication",
    "acquiror":"Astellas",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Phase III",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"4/15/2010",
    "currency":"$",
    "headline":"130+",
    "upfront":"130",
    "ms":"MS+RoS",
    "equityStake":"Yes",
    "acquired":"Agios",
    "acquiror":"Celgene",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Discovery",
    "comment":"Research collaboration (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"6/17/2010",
    "currency":"$",
    "headline":"539.5+",
    "upfront":"40",
    "ms":"MS+RoS",
    "equityStake":"No",
    "acquired":"Oncomed",
    "acquiror":"Bayer",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Discovery",
    "comment":"Research collaboration (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"4/13/2011",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Amunix",
    "acquiror":"Amunix",
    "scope":"WW",
    "txArea":"Haemotology",
    "stage":"Discovery",
    "comment":"Research collaboration (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"9/20/2011",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Ono Pharmaceutical",
    "acquiror":"Bristol Myers Squibb",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"",
    "comment":"Product license (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"12/8/2011",
    "currency":"",
    "headline":"975",
    "upfront":"150",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Pharmacyclics",
    "acquiror":"J&J",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"PII",
    "comment":"Product license (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"1/5/2012",
    "currency":"$",
    "headline":"815",
    "upfront":"65",
    "ms":"MS",
    "equityStake":"",
    "acquired":"Forma Therapeutics",
    "acquiror":"Boehringer Ingelheim",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Discovery",
    "comment":"Platform license (discovery)",
    "detail":""
  },
  {
    "dateAnnounced":"1/6/2012",
    "currency":"$",
    "headline":"180",
    "upfront":"30",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"BioDelivery Sciences",
    "acquiror":"Endo Pharmaceuticals",
    "scope":"WW",
    "txArea":"Chronic Pain",
    "stage":"Phase III",
    "comment":"Product license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"1/10/2012",
    "currency":"$",
    "headline":"700+",
    "upfront":"ND",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Forma Therapeutics",
    "acquiror":"J&J",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Discovery",
    "comment":"Platform license (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"2/21/2012",
    "currency":"$",
    "headline":"440",
    "upfront":"34",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Enanta Pharmaceuticals",
    "acquiror":"Novartis",
    "scope":"WW",
    "txArea":"HCV",
    "stage":"Phase I",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"2/29/2012",
    "currency":"$",
    "headline":"1100+",
    "upfront":"150",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Galapagos",
    "acquiror":"Abbott",
    "scope":"WW",
    "txArea":"Diabetes",
    "stage":"Phase II",
    "comment":"Product license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"4/16/2012",
    "currency":"$",
    "headline":"1000",
    "upfront":"120",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Endocyte",
    "acquiror":"Merck & Co",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Phase III",
    "comment":"Product license (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"4/16/2012",
    "currency":"$",
    "headline":"1000+",
    "upfront":"120",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Endocyte",
    "acquiror":"Merck&Co",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Phase III",
    "comment":"Product license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"4/17/2012",
    "currency":"$",
    "headline":"165+",
    "upfront":"30",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"FivePrime Therapeutics ",
    "acquiror":"GSK",
    "scope":"WW",
    "txArea":"Respiratory",
    "stage":"Discovery",
    "comment":"Discovery",
    "detail":""
  },
  {
    "dateAnnounced":"4/30/2012",
    "currency":"$",
    "headline":"130",
    "upfront":"ND",
    "ms":"ND",
    "equityStake":"",
    "acquired":"Tolero",
    "acquiror":"Mannkind",
    "scope":"WW",
    "txArea":"Oncology + Inflammation",
    "stage":"Preclinical",
    "comment":"Discovery & Development",
    "detail":""
  },
  {
    "dateAnnounced":"6/4/2012",
    "currency":"$",
    "headline":"175",
    "upfront":"2",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Genmab",
    "acquiror":"Novartis",
    "scope":"WW",
    "txArea":"Undisclosed",
    "stage":"Discovery",
    "comment":"Platform license (develop)",
    "detail":""
  },
  {
    "dateAnnounced":"8/6/2012",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"U of Penn",
    "acquiror":"Novartis",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Phase I",
    "comment":"Platform license/Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"8/30/2012",
    "currency":"$",
    "headline":"1100",
    "upfront":"55",
    "ms":"MS+RoS",
    "equityStake":"Yes",
    "acquired":"GSK",
    "acquiror":"J&J",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Phase I/II",
    "comment":"Product license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"10/12/2012",
    "currency":"EUR",
    "headline":"442.5+",
    "upfront":"110",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"AiCuris",
    "acquiror":"Merck&Co",
    "scope":"WW",
    "txArea":"Vaccines",
    "stage":"Preclinical ",
    "comment":"Portfolio license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"1/7/2013",
    "currency":"$",
    "headline":"1150",
    "upfront":"30",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"MacroGenics",
    "acquiror":"Gilead",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Preclinical",
    "comment":"Platform license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"2/21/2013",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Merck & Co",
    "acquiror":"Samsung (Bioepis JV)",
    "scope":"WW",
    "txArea":"Biosimlars",
    "stage":"Preclinical",
    "comment":"Platform license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"3/21/2013",
    "currency":"$",
    "headline":"ND",
    "upfront":"ND",
    "ms":"225",
    "equityStake":"",
    "acquired":"Bluebird bio/Baylor College of Medicine",
    "acquiror":"Celgene",
    "scope":"WW",
    "txArea":" Oncology (CAR-T)",
    "stage":"",
    "comment":"Platform license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"3/28/2013",
    "currency":"$",
    "headline":"545+",
    "upfront":"50",
    "ms":"495",
    "equityStake":"",
    "acquired":"Edison Pharmaceuticals",
    "acquiror":"Dainippon Sumitomo",
    "scope":"Japan",
    "txArea":"Orphan diseases (miRNA)",
    "stage":"Phase II",
    "comment":"Research collaboration (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"4/29/2013",
    "currency":"$",
    "headline":"60+",
    "upfront":"60",
    "ms":"MS+RoS",
    "equityStake":"No",
    "acquired":"Merck & Co",
    "acquiror":"Pfizer",
    "scope":"WW",
    "txArea":" Diabetes",
    "stage":"Phase III",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"4/29/2013",
    "currency":"$",
    "headline":"200+",
    "upfront":"ND",
    "ms":"200",
    "equityStake":"",
    "acquired":"Forma Therapeutics",
    "acquiror":"Celgene",
    "scope":"WW",
    "txArea":" Multiple",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"5/15/2013",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Merck KGaA (R&D)",
    "acquiror":"Quintiles",
    "scope":"WW",
    "txArea":"R&D",
    "stage":"Phase I - postmarketing",
    "comment":"Research alliance (outsourcing)",
    "detail":""
  },
  {
    "dateAnnounced":"6/25/2013",
    "currency":"$",
    "headline":"490",
    "upfront":"",
    "ms":"450",
    "equityStake":"Yes",
    "acquired":"Cytokinetics",
    "acquiror":"Astellas",
    "scope":"WW",
    "txArea":"Muscular Diseas",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"9/4/2013",
    "currency":"$",
    "headline":"35",
    "upfront":"15",
    "ms":"20",
    "equityStake":"",
    "acquired":"Pozen",
    "acquiror":"Sanofi",
    "scope":"WW",
    "txArea":"Pain",
    "stage":"Filed",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"10/29/2013",
    "currency":"$",
    "headline":"1800",
    "upfront":"200",
    "ms":"1580",
    "equityStake":"",
    "acquired":"Pfizer",
    "acquiror":"Eli Lilly",
    "scope":"WW",
    "txArea":"Pain",
    "stage":"Phase III",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"11/8/2013",
    "currency":"$",
    "headline":"1796.5",
    "upfront":"60",
    "ms":"",
    "equityStake":"",
    "acquired":"Arena",
    "acquiror":"Eisai",
    "scope":"WW ",
    "txArea":"Obesity",
    "stage":"Marketed",
    "comment":"Product license (expanded marketing and supply agreement)",
    "detail":""
  },
  {
    "dateAnnounced":"11/13/2013",
    "currency":"$",
    "headline":"1017",
    "upfront":"17",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Immatics biotechnologies",
    "acquiror":"Roche",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Phase I - ready",
    "comment":"Research collaboration ",
    "detail":""
  },
  {
    "dateAnnounced":"12/2/2013",
    "currency":"$",
    "headline":"240+",
    "upfront":"240",
    "ms":"MS",
    "equityStake":"",
    "acquired":"Forest",
    "acquiror":"Merck & Co (Saphris)",
    "scope":"US",
    "txArea":"CNS (schizophrenia)",
    "stage":"Marketed",
    "comment":"Product acquisition (marketing rights)",
    "detail":""
  },
  {
    "dateAnnounced":"12/3/2013",
    "currency":"$",
    "headline":"3332",
    "upfront":"178",
    "ms":"3000",
    "equityStake":"Yes",
    "acquired":"Oncomed",
    "acquiror":"Celgene",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Phase Ib/II",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"12/4/2013",
    "currency":"$",
    "headline":"1169",
    "upfront":"61",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Molecular Partners",
    "acquiror":"Roche",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Discovery",
    "comment":"Research collaboration ",
    "detail":""
  },
  {
    "dateAnnounced":"1/6/2014",
    "currency":"$",
    "headline":"337.5",
    "upfront":"12.5",
    "ms":"MS+RoS",
    "equityStake":"No",
    "acquired":"Capricor Therapeutics",
    "acquiror":"J&J",
    "scope":"WW",
    "txArea":"CVD",
    "stage":"PII",
    "comment":"Research collaboration (exculsive) ",
    "detail":""
  },
  {
    "dateAnnounced":"1/7/2014",
    "currency":"$",
    "headline":"510",
    "upfront":"510",
    "ms":"RoS",
    "equityStake":"No",
    "acquired":"Biogen Idec",
    "acquiror":"Royalty Pharma",
    "scope":"WW/Germany",
    "txArea":"MS/Psoriasis",
    "stage":"Marketed",
    "comment":"Product license (royalty)",
    "detail":""
  },
  {
    "dateAnnounced":"1/7/2014",
    "currency":"$",
    "headline":"88+",
    "upfront":"ND",
    "ms":"88",
    "equityStake":"No",
    "acquired":"Horizon",
    "acquiror":"AstraZeneca",
    "scope":"WW",
    "txArea":"Oncology (siRNA)",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"1/8/2014",
    "currency":"$",
    "headline":"ND",
    "upfront":"20",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Immunocor",
    "acquiror":"AstraZeneca",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Discovery",
    "comment":"Platform license (discovery & development) ",
    "detail":""
  },
  {
    "dateAnnounced":"1/9/2014",
    "currency":"$",
    "headline":"320",
    "upfront":"20",
    "ms":"300",
    "equityStake":"",
    "acquired":"Sangamo Biosciences",
    "acquiror":"Biogen Idec",
    "scope":"WW",
    "txArea":"Gene therapy (Blood disorders)",
    "stage":"Discovery",
    "comment":"Research collaboration (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"1/9/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Pfizer (Bosulif)",
    "acquiror":"Avillion",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Phase III",
    "comment":"Product license (development & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"1/9/2014",
    "currency":"$",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"CytomX Therapeutics",
    "acquiror":"Immunogen",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"1/9/2014",
    "currency":"$",
    "headline":"148+",
    "upfront":"10",
    "ms":"",
    "equityStake":"",
    "acquired":"Santaris",
    "acquiror":"Roche",
    "scope":"WW",
    "txArea":"RNAi",
    "stage":"Multiple",
    "comment":"Platform license (development & commercialisation)",
    "detail":""
  },
  {
    "dateAnnounced":"1/9/2014",
    "currency":"$",
    "headline":"100+",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Cancer Prevention Pharmaceuticals",
    "acquiror":"Zeria Tillots Pharma",
    "scope":"Europe/Japan",
    "txArea":"Orphan Diseases (mRNA)",
    "stage":"",
    "comment":"Product license (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"1/10/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Santaris",
    "acquiror":"GSK",
    "scope":"WW",
    "txArea":"RNAi",
    "stage":"Not disclosed",
    "comment":"Platform license (development & commercialisation)",
    "detail":""
  },
  {
    "dateAnnounced":"1/13/2014",
    "currency":"$",
    "headline":"700",
    "upfront":"ND",
    "ms":"ND",
    "equityStake":"Yes",
    "acquired":"Alnylam",
    "acquiror":"Sanofi (Genzyme)",
    "scope":"WW",
    "txArea":"RNAi",
    "stage":"Orphan disease",
    "comment":"Platform license (development & commercialisation)",
    "detail":""
  },
  {
    "dateAnnounced":"1/13/2014",
    "currency":"$",
    "headline":"125+",
    "upfront":"125",
    "ms":"MS+RoS",
    "equityStake":"Yes",
    "acquired":"Moderna Therapeutics",
    "acquiror":"Alexion",
    "scope":"WW",
    "txArea":"Orphan Diseases (mRNA)",
    "stage":"Discovery",
    "comment":"Research collaboration (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"1/13/2014",
    "currency":"$",
    "headline":"75",
    "upfront":"",
    "ms":"",
    "equityStake":"Yes",
    "acquired":"NantBioscience",
    "acquiror":"Celgene",
    "scope":"WW",
    "txArea":"",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"1/14/2014",
    "currency":"$",
    "headline":"75",
    "upfront":"ND",
    "ms":"MS",
    "equityStake":"No",
    "acquired":"Living Proof",
    "acquiror":"Valeant",
    "scope":"WW",
    "txArea":"Dermatology",
    "stage":"Discovery",
    "comment":"Platform license (development & commercialisation)",
    "detail":""
  },
  {
    "dateAnnounced":"1/14/2014",
    "currency":"$",
    "headline":"397",
    "upfront":"125",
    "ms":"272",
    "equityStake":"",
    "acquired":"Aerial Biopharma",
    "acquiror":"Jazz Pharmaceuticals",
    "scope":"WW",
    "txArea":"Narcolepsy",
    "stage":"Phase III",
    "comment":"Product license (acquisition)",
    "detail":""
  },
  {
    "dateAnnounced":"1/31/2014",
    "currency":"$",
    "headline":"105",
    "upfront":"ND",
    "ms":"MS+RoS",
    "equityStake":"Yes",
    "acquired":"Edison Pharmaceuticals",
    "acquiror":"Dainippon Sumitomo",
    "scope":"US",
    "txArea":"Orphan Diseases (miRNA)",
    "stage":"Discovery",
    "comment":"License extension",
    "detail":""
  },
  {
    "dateAnnounced":"2/3/2014",
    "currency":"€",
    "headline":"1700",
    "upfront":"20",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Ablynx",
    "acquiror":"Merck & Co",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Discovery",
    "comment":"Research collaboration (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"2/5/2014",
    "currency":"$",
    "headline":">60",
    "upfront":"ND",
    "ms":"ND",
    "equityStake":"",
    "acquired":"Zosano (Macroflux)",
    "acquiror":"Novo Norddisk",
    "scope":"WW",
    "txArea":"Diabetes",
    "stage":"Pre-clinical",
    "comment":"Platform license (development & commercialisation)",
    "detail":""
  },
  {
    "dateAnnounced":"2/5/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Incyte Corp",
    "acquiror":"Merck & Co",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Phase I",
    "comment":"Research collaboration (non-exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"2/10/2014",
    "currency":"$",
    "headline":"51",
    "upfront":"ND",
    "ms":"ND",
    "equityStake":"",
    "acquired":"Apricus Biosciences",
    "acquiror":"Recordati",
    "scope":"Europe",
    "txArea":"Men's health",
    "stage":"Marketed",
    "comment":"Product license (commercialisation)",
    "detail":""
  },
  {
    "dateAnnounced":"2/17/2014",
    "currency":"$",
    "headline":"900",
    "upfront":"10",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Cellectis",
    "acquiror":"Servier",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Discovery",
    "comment":"Platform license (discovery & development)",
    "detail":""
  },
  {
    "dateAnnounced":"2/24/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Advaxis (ADSX-HPV)",
    "acquiror":"AstraZeneca (MEDI4736)",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase I",
    "comment":"Clinical trial collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"2/25/2014",
    "currency":"$",
    "headline":"198",
    "upfront":"ND",
    "ms":"MS",
    "equityStake":"",
    "acquired":"Ardelyx",
    "acquiror":"Sanofi",
    "scope":"WW",
    "txArea":"CKD",
    "stage":"Preclinical",
    "comment":"Platform license (discovery & development)",
    "detail":""
  },
  {
    "dateAnnounced":"2/28/2014",
    "currency":"$",
    "headline":"ND",
    "upfront":"50",
    "ms":"MS",
    "equityStake":"Yes",
    "acquired":"Abide Therapeutics",
    "acquiror":"Celgene",
    "scope":"WW",
    "txArea":"Immunology + Inflammation",
    "stage":"Discovery",
    "comment":"Platform license (discovery & development)",
    "detail":""
  },
  {
    "dateAnnounced":"3/11/2014",
    "currency":"$",
    "headline":"167",
    "upfront":"ND",
    "ms":"167",
    "equityStake":"No",
    "acquired":"Caisson Biotech",
    "acquiror":"Novo Nordisk",
    "scope":"WW",
    "txArea":"Diabetes/Inflammatory",
    "stage":"Pre-clinical",
    "comment":"Platform license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"3/11/2014",
    "currency":"EUR",
    "headline":"100",
    "upfront":"ND",
    "ms":"MS",
    "equityStake":"No",
    "acquired":"UCB",
    "acquiror":"Sanofi",
    "scope":"WW",
    "txArea":"Inflammatory",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"3/13/2014",
    "currency":"$",
    "headline":"125",
    "upfront":"17",
    "ms":"MS+RoS",
    "equityStake":"No",
    "acquired":"AnaptysBio",
    "acquiror":"Tesaro",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Pre-clinical",
    "comment":"Research collaboration (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"3/14/2014",
    "currency":"EUR",
    "headline":"76",
    "upfront":"1",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"TxCell",
    "acquiror":"Ferring",
    "scope":"WW",
    "txArea":"IBD",
    "stage":"Phase II",
    "comment":"Product license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"3/17/2014",
    "currency":"$",
    "headline":"350",
    "upfront":"20",
    "ms":"MS+RoS",
    "equityStake":"Yes",
    "acquired":"FivePrime Therapeutics",
    "acquiror":"Bristol-Myers Squibb",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Discovery",
    "comment":"Research collaboration (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"3/19/2014",
    "currency":"$",
    "headline":"23",
    "upfront":"23",
    "ms":"ND",
    "equityStake":"No",
    "acquired":"SK Chemicals",
    "acquiror":"Sanofi",
    "scope":"WW",
    "txArea":"Vaccines",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"3/27/2014",
    "currency":"Yes",
    "headline":"20,000",
    "upfront":"20,000",
    "ms":"MS",
    "equityStake":"No",
    "acquired":"Takeda",
    "acquiror":"Otsuka",
    "scope":"Japan",
    "txArea":"GI",
    "stage":"Filed",
    "comment":"Product license (co-promotion)",
    "detail":""
  },
  {
    "dateAnnounced":"4/1/2014",
    "currency":"$",
    "headline":"600",
    "upfront":"225",
    "ms":"MS",
    "equityStake":"Yes",
    "acquired":"Forma Therapeutics",
    "acquiror":"Celgene",
    "scope":"ex-US",
    "txArea":"Multiple",
    "stage":"Discovery",
    "comment":"Research collaboration (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"4/7/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Mersana Therapeutics",
    "acquiror":"Takeda",
    "scope":"WW",
    "txArea":"Oncology (ADC)",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"4/22/2014",
    "currency":"$",
    "headline":"174",
    "upfront":"0",
    "ms":"174",
    "equityStake":"",
    "acquired":"Sentinel Oncology",
    "acquiror":"Oncothyreon",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Pre-clinical",
    "comment":"Research collaboration (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"4/23/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"ND",
    "ms":"MS+RoS",
    "equityStake":"No",
    "acquired":"OncoFusion",
    "acquiror":"Medivation",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Discovery (pre-clinical)",
    "comment":"Research agreement/Product license",
    "detail":""
  },
  {
    "dateAnnounced":"4/24/2014",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Biogen Idec (R&D)",
    "acquiror":"Quintiles",
    "scope":"WW",
    "txArea":" R&D",
    "stage":"Clinical (Phase II-IV)",
    "comment":"Research alliance (outsourcing)",
    "detail":""
  },
  {
    "dateAnnounced":"4/24/2014",
    "currency":"$",
    "headline":"2600",
    "upfront":"710",
    "ms":"MS",
    "equityStake":"No",
    "acquired":"Nogra Pharma",
    "acquiror":"Celgene",
    "scope":"WW",
    "txArea":"Crohn's disease (RNAi)",
    "stage":"Phase III",
    "comment":"Product license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"4/24/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"ND",
    "ms":"MS+RoS",
    "equityStake":"No",
    "acquired":"Hydra Biosciences",
    "acquiror":"Boehringer",
    "scope":"WW",
    "txArea":"CNS",
    "stage":"Discovery",
    "comment":"Research collaboration (discovery & development)",
    "detail":""
  },
  {
    "dateAnnounced":"4/28/2014",
    "currency":"$",
    "headline":"100",
    "upfront":"ND",
    "ms":"MS+RoS",
    "equityStake":"No",
    "acquired":"Agenus",
    "acquiror":"Merck & Co",
    "scope":"WW",
    "txArea":"Immuno-oncology",
    "stage":"Discovery",
    "comment":"Platform license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"5/5/2014",
    "currency":"$",
    "headline":"640",
    "upfront":"ND",
    "ms":"640",
    "equityStake":"No",
    "acquired":"Avalanche",
    "acquiror":"Regeneron",
    "scope":"WW",
    "txArea":"Ophthalmology",
    "stage":"Discovery",
    "comment":"Platform license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"5/6/2014",
    "currency":"$",
    "headline":"2100",
    "upfront":"1000",
    "ms":"MS (sales)",
    "equityStake":"No",
    "acquired":"Bayer",
    "acquiror":"Merck & Co",
    "scope":"WW",
    "txArea":" CVD",
    "stage":"Marketed/Phase II",
    "comment":"Product license(s) (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"5/14/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Incyte Corp",
    "acquiror":"Astrazeneca (MedImmune)",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase I/II",
    "comment":"Research collaboration (non-exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"5/14/2014",
    "currency":"$",
    "headline":"5",
    "upfront":"5",
    "ms":"",
    "equityStake":"No",
    "acquired":"Celldex Therapeutics",
    "acquiror":"Bristol-Myers Squibb",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase I/II",
    "comment":"Research collaboration (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"5/14/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"CSL",
    "acquiror":"Aslan Pharmaceuticals",
    "scope":"WW",
    "txArea":" Respiratory",
    "stage":"Pre-clinical",
    "comment":"Product license (develop)",
    "detail":""
  },
  {
    "dateAnnounced":"5/14/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Servier",
    "acquiror":"Novartis",
    "scope":"TBD",
    "txArea":" Oncology",
    "stage":"Pre-clinical",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"5/17/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"No",
    "acquired":"Jai Capital",
    "acquiror":"Akers Biosciences",
    "scope":"India",
    "txArea":" Diagnostics",
    "stage":"Marketed",
    "comment":"Distribution partnership",
    "detail":""
  },
  {
    "dateAnnounced":"5/19/2014",
    "currency":"$",
    "headline":"1,030",
    "upfront":"200",
    "ms":"MS+Ros",
    "equityStake":"No",
    "acquired":"Ophthotech",
    "acquiror":"Novartis",
    "scope":"ex-US",
    "txArea":" Ophthalmology",
    "stage":"Phase III",
    "comment":"Product license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"5/20/2014",
    "currency":"",
    "headline":" ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Celgene",
    "acquiror":"AADi LLC",
    "scope":"WW",
    "txArea":" Oncology + CVD",
    "stage":"Phase I/II",
    "comment":"Product license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"5/22/2014",
    "currency":"",
    "headline":" ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Viking Therapeutics",
    "acquiror":"Ligand Pharmaceuticals",
    "scope":"",
    "txArea":" Metabolic/Endocrine disease",
    "stage":"",
    "comment":"Product license (develop)",
    "detail":""
  },
  {
    "dateAnnounced":"5/27/2014",
    "currency":"$",
    "headline":"722",
    "upfront":"15",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"MacroGenics",
    "acquiror":"Takeda",
    "scope":"WW",
    "txArea":" Autoimmune disorders",
    "stage":"Pre-clinical",
    "comment":"Product license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"5/27/2014",
    "currency":"$",
    "headline":"1,242",
    "upfront":"50",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"CytomX Therapeutics",
    "acquiror":"Bristol-Myers Squibb",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Pre-clinical",
    "comment":"Product license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"5/27/2014",
    "currency":"$",
    "headline":" ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Incyte Corp",
    "acquiror":"Bristol-Myers Squibb",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase I/II",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"5/29/2014",
    "currency":"$",
    "headline":"365",
    "upfront":"ND",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Aduro Bio Tech Inc",
    "acquiror":"Johnson & Johnson (Janssen)",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Pre-clinical",
    "comment":"Platform license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"6/2/2014",
    "currency":"$",
    "headline":" ND",
    "upfront":"68",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Orion",
    "acquiror":"Bayer",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase III",
    "comment":"Product license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"6/2/2014",
    "currency":"$",
    "headline":"350",
    "upfront":"ND",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Adaptimmune",
    "acquiror":"GSK",
    "scope":"WW",
    "txArea":" Oncology (CAR-T)",
    "stage":"Phase I/II",
    "comment":"Platform license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"6/12/2014",
    "currency":"$",
    "headline":"232",
    "upfront":"7.3",
    "ms":"225",
    "equityStake":"No",
    "acquired":"Synairgen ",
    "acquiror":"Astrazeneca",
    "scope":"WW",
    "txArea":" Respiratory",
    "stage":"Phase I",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"6/12/2014",
    "currency":"",
    "headline":" ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Morphosys",
    "acquiror":"Merck KGaA",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"6/13/2014",
    "currency":"$",
    "headline":"140",
    "upfront":"20",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Agios",
    "acquiror":"Celgene",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase I",
    "comment":"Product license (option exercise)",
    "detail":""
  },
  {
    "dateAnnounced":"6/14/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Medtronic",
    "acquiror":"Sanofi",
    "scope":"WW",
    "txArea":" Diabetes",
    "stage":"",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"6/18/2014",
    "currency":"$",
    "headline":"2,800",
    "upfront":"80",
    "ms":"MS+RoS",
    "equityStake":"Y (10%)",
    "acquired":"Cellectis",
    "acquiror":"Pfizer",
    "scope":"WW",
    "txArea":" Oncology (CAR-T)",
    "stage":"Preclinical",
    "comment":"Platform license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"6/19/2014",
    "currency":"$",
    "headline":"30+",
    "upfront":"30",
    "ms":"MS",
    "equityStake":"No",
    "acquired":"Vertex",
    "acquiror":"J&J",
    "scope":"WW",
    "txArea":" Cystic Fibrosis",
    "stage":"Phase II",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"6/23/2014",
    "currency":"$",
    "headline":"252",
    "upfront":"20",
    "ms":"MS+RoS",
    "equityStake":"No",
    "acquired":"Dimension",
    "acquiror":"Bayer",
    "scope":"WW",
    "txArea":" Haemophilia A (Gene Tx)",
    "stage":"Preclinical",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"6/25/2014",
    "currency":"$",
    "headline":"526",
    "upfront":"20",
    "ms":"MS+RoS",
    "equityStake":"No",
    "acquired":"Bionomics",
    "acquiror":"Merck & Co",
    "scope":"WW",
    "txArea":" CNS",
    "stage":"Preclinical",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"6/25/2014",
    "currency":"$",
    "headline":"10",
    "upfront":"",
    "ms":"",
    "equityStake":"No",
    "acquired":"Dana-Farber",
    "acquiror":"J&J",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"6/25/2014",
    "currency":"$",
    "headline":"792",
    "upfront":"ND",
    "ms":"MS+RoS",
    "equityStake":"No",
    "acquired":"Mersana Therapeutics",
    "acquiror":"Merck KGaA",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Preclinical",
    "comment":"Platform license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"6/26/2014",
    "currency":"",
    "headline":" ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Sigma-tau Group",
    "acquiror":"Teijin Pharma",
    "scope":"Japan",
    "txArea":" Orphan Disease (SCID)",
    "stage":"Phase III",
    "comment":"Product license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"7/2/2014",
    "currency":"$",
    "headline":"250",
    "upfront":"75",
    "ms":"175",
    "equityStake":"No",
    "acquired":"Sigma-tau Group",
    "acquiror":"Jazz Pharmaceuticals",
    "scope":"US",
    "txArea":" Orphan Disease ",
    "stage":"Phase III",
    "comment":"Product license (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"7/4/2014",
    "currency":"$",
    "headline":"110",
    "upfront":"5",
    "ms":"MS+RoS",
    "equityStake":"Yes",
    "acquired":"UCB (Cimzia)",
    "acquiror":"Dermira Inc",
    "scope":"North America",
    "txArea":" Autoimmne disorders",
    "stage":"Phase III",
    "comment":"Product license (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"7/8/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Eli Lilly",
    "acquiror":"Yabao Pharmaceutical",
    "scope":"China",
    "txArea":" Diabetes",
    "stage":"Phase I",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"7/9/2014",
    "currency":"$",
    "headline":"30",
    "upfront":"30",
    "ms":"",
    "equityStake":"No",
    "acquired":"Supernus Pharmaceuticals",
    "acquiror":"HealthCare Royalty",
    "scope":"US",
    "txArea":" CVD",
    "stage":"Marketed",
    "comment":"Product license (royalty)",
    "detail":""
  },
  {
    "dateAnnounced":"7/14/2014",
    "currency":"$",
    "headline":"65",
    "upfront":"6",
    "ms":"MS+RoS",
    "equityStake":"M",
    "acquired":"Codexis",
    "acquiror":"GSK",
    "scope":"WW",
    "txArea":" N/A",
    "stage":"Discovery",
    "comment":"Platform license (non-exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"7/21/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Advaxis",
    "acquiror":"Astrazeneca",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase I/II",
    "comment":"Research collaboration (non-exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"7/23/2014",
    "currency":"$",
    "headline":"225",
    "upfront":"15",
    "ms":"210",
    "equityStake":"Yes",
    "acquired":"ArmaGen",
    "acquiror":"Shire",
    "scope":"WW",
    "txArea":" Orphan Disease (Hunters Syndrome)",
    "stage":"",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"7/24/2014",
    "currency":"$",
    "headline":"526",
    "upfront":"20",
    "ms":"MS+RoS",
    "equityStake":"No",
    "acquired":"Bionomics",
    "acquiror":"Merck & Co",
    "scope":"WW",
    "txArea":" CNS",
    "stage":"Preclinical",
    "comment":"Research collaboration (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"7/25/2014",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Bristol Myers Squibb",
    "acquiror":"Ono Pharmaceutical",
    "scope":"SE Asia",
    "txArea":" Oncology",
    "stage":"",
    "comment":"Research collaboration ",
    "detail":""
  },
  {
    "dateAnnounced":"7/28/2014",
    "currency":"€",
    "headline":"301",
    "upfront":"6",
    "ms":"295",
    "equityStake":"No",
    "acquired":"Boehringer Ingelheim",
    "acquiror":"Zealand Pharma",
    "scope":"WW",
    "txArea":" Cardio-metabolic",
    "stage":"Pre-clinical",
    "comment":"Research collaboration (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"7/29/2014",
    "currency":"$",
    "headline":"107",
    "upfront":"0",
    "ms":"107",
    "equityStake":"",
    "acquired":"Amorchem",
    "acquiror":"Roche",
    "scope":"WW",
    "txArea":" Orphan disease (Steinert's Disease)",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"7/30/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Incyte Corp",
    "acquiror":"Roche (Genentech)",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase I",
    "comment":"Research collaboration (non-exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"7/30/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Kyowa Hakko Kirin",
    "acquiror":"Astrazeneca",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase I/Ib",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"8/4/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Boehringer Ingelheim",
    "acquiror":"Medivir",
    "scope":"WW",
    "txArea":" Infectious disease (RSV)",
    "stage":"Discovery",
    "comment":"Product license (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"8/5/2014",
    "currency":"$",
    "headline":"ND",
    "upfront":"2",
    "ms":"MS",
    "equityStake":"",
    "acquired":"Regulus",
    "acquiror":"Biogen Idc",
    "scope":"WW",
    "txArea":" MS",
    "stage":"",
    "comment":"Platform license",
    "detail":""
  },
  {
    "dateAnnounced":"8/7/2014",
    "currency":"$",
    "headline":"168",
    "upfront":"ND",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Immune Design",
    "acquiror":"Sanofi",
    "scope":"WW",
    "txArea":" Allergy",
    "stage":"Discovery",
    "comment":"Platform license",
    "detail":""
  },
  {
    "dateAnnounced":"8/7/2014",
    "currency":"$",
    "headline":"650",
    "upfront":"100",
    "ms":"550",
    "equityStake":"",
    "acquired":"Charleston Laboratories",
    "acquiror":"Daiichi Sankyo",
    "scope":"WW",
    "txArea":" Pain",
    "stage":"Phase III",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"8/8/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"CRUK",
    "acquiror":"Astellas",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Dsicovery",
    "comment":"Research collaboration (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"8/11/2014",
    "currency":"$",
    "headline":"925",
    "upfront":"150",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"MannKind",
    "acquiror":"Sanofi",
    "scope":"WW",
    "txArea":" Diabetes",
    "stage":"Marketed",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"8/19/2014",
    "currency":"$",
    "headline":"183",
    "upfront":"20",
    "ms":"163",
    "equityStake":"",
    "acquired":"Emergent BioSolutions",
    "acquiror":"Morphosys",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"8/20/2014",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Celgene",
    "acquiror":"Bristol-Myers Squibb",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase I",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"8/25/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Advaxis (ADXS-PSA)",
    "acquiror":"Merck (pembrolizumab)",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase I",
    "comment":"Clinical trial collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"9/1/2014",
    "currency":"€",
    "headline":"ND",
    "upfront":"2",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Ablynx",
    "acquiror":"EddingPharm",
    "scope":"China",
    "txArea":" Autoimmune disorders (RA)",
    "stage":"Phase IIa PoC",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"9/4/2014",
    "currency":"$",
    "headline":"1,500",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Abbvie",
    "acquiror":"Calico LLC (Google)",
    "scope":"WW",
    "txArea":" Anti-aging",
    "stage":"Discovery",
    "comment":"Research colaboration",
    "detail":""
  },
  {
    "dateAnnounced":"9/4/2014",
    "currency":"$",
    "headline":"805",
    "upfront":"275",
    "ms":"530",
    "equityStake":"",
    "acquired":"Infinity Pharmaceuticals",
    "acquiror":"Abbvie",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase III",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"9/8/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"University of Toronto",
    "acquiror":"J&J",
    "scope":"WW",
    "txArea":" Neuroscience",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"9/9/2014",
    "currency":"$",
    "headline":"150",
    "upfront":"ND",
    "ms":"",
    "equityStake":"",
    "acquired":"NeuroVive",
    "acquiror":"OnCore Biopharma",
    "scope":"WW",
    "txArea":" Hepatitis B Virus",
    "stage":"Preclinical",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"9/11/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"2M",
    "acquiror":"Callico LLC (Google)",
    "scope":"WW",
    "txArea":" Neurodegenerative disease",
    "stage":"Preclinical",
    "comment":"Product license(s) (develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"9/11/2014",
    "currency":"$",
    "headline":"211",
    "upfront":"11",
    "ms":"",
    "equityStake":"",
    "acquired":"Seattle Genetics",
    "acquiror":"Genmab",
    "scope":"WW",
    "txArea":" Antibodies",
    "stage":"Preclinical",
    "comment":"Platform license",
    "detail":""
  },
  {
    "dateAnnounced":"9/15/2014",
    "currency":"$",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Salix",
    "acquiror":"Lupin",
    "scope":"Canada",
    "txArea":" Gastroenetrology",
    "stage":"Marketed",
    "comment":"Distribution partnership",
    "detail":""
  },
  {
    "dateAnnounced":"9/15/2014",
    "currency":"$",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Gilead",
    "acquiror":"7 Gx (Incl Mylan, Ranbaxy etc)",
    "scope":"Developing countries",
    "txArea":" HCV",
    "stage":"Marketed",
    "comment":"Product license (non-exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"9/16/2014",
    "currency":"$",
    "headline":"500",
    "upfront":"50",
    "ms":"MS",
    "equityStake":"",
    "acquired":"AstraZeneca (AZD3293)",
    "acquiror":"Eli Lilly",
    "scope":"WW",
    "txArea":" Alzheimers",
    "stage":"Phase II/III",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"9/17/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Pfizer (Xalkori)",
    "acquiror":"Merck (pembrolizumab)",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase I",
    "comment":"Clinical trial collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"9/30/2014",
    "currency":"$",
    "headline":"400",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"MacroGenics",
    "acquiror":"Takeda",
    "scope":"WW",
    "txArea":" Autoimmune disorders",
    "stage":"Discovery (?)",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"10/3/2014",
    "currency":"$",
    "headline":"45",
    "upfront":"35",
    "ms":"10",
    "equityStake":"Y ($15m)",
    "acquired":"Rockwell Medical",
    "acquiror":"Baxter",
    "scope":"WW",
    "txArea":" Kidney disease",
    "stage":"Marketed",
    "comment":"Distribution agreement (exclusive",
    "detail":""
  },
  {
    "dateAnnounced":"10/6/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Bristol Myers Squibb",
    "acquiror":"Novartis",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase I/II",
    "comment":"Research collaboration (combo studies)",
    "detail":""
  },
  {
    "dateAnnounced":"10/10/2014",
    "currency":"$",
    "headline":"90",
    "upfront":"14",
    "ms":"MS+RoS",
    "equityStake":"Y ($4.3m)",
    "acquired":"Oxford Biomedica",
    "acquiror":"Novartis",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Discovery",
    "comment":"Platform license (non-exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"10/16/2014",
    "currency":"$",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Immune Design",
    "acquiror":"Sanofi",
    "scope":"WW",
    "txArea":" HSV",
    "stage":"Phase I",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"10/16/2014",
    "currency":"$",
    "headline":"847",
    "upfront":"30",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Aduro Biotech",
    "acquiror":"J&J",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"ND",
    "comment":"Platform license (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"10/20/2014",
    "currency":"$",
    "headline":"1,000",
    "upfront":"150",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"NewLink",
    "acquiror":"Roche (Genetech)",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase I",
    "comment":"Product license (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"11/4/2014",
    "currency":"$",
    "headline":"1,200",
    "upfront":"ND",
    "ms":"",
    "equityStake":"",
    "acquired":"Proteostasis Therapeutics",
    "acquiror":"Astellas Inc",
    "scope":"WW",
    "txArea":" Protein misfolding",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"11/6/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Bind Therapeutics ",
    "acquiror":"Merck & Co",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Discovery",
    "comment":"Platform license",
    "detail":""
  },
  {
    "dateAnnounced":"11/12/2014",
    "currency":"$",
    "headline":"1000+",
    "upfront":"171",
    "ms":"",
    "equityStake":"",
    "acquired":"Intarcia",
    "acquiror":"Servier",
    "scope":"ex-US",
    "txArea":" Diabetes",
    "stage":"Phase III",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"11/13/2014",
    "currency":"$",
    "headline":"935",
    "upfront":"35",
    "ms":"900",
    "equityStake":"",
    "acquired":"Geron",
    "acquiror":"JNJ",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase II",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"11/17/2014",
    "currency":"$",
    "headline":"2,850",
    "upfront":"850",
    "ms":"2000",
    "equityStake":"",
    "acquired":"Merck KGaA",
    "acquiror":"Pfizer",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Pre-clincal",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"11/18/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Clovis Oncology",
    "acquiror":"GSK",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase I",
    "comment":"Research collaboration (combo studies)",
    "detail":""
  },
  {
    "dateAnnounced":"11/24/2014",
    "currency":"$",
    "headline":"~300",
    "upfront":"ND",
    "ms":"292",
    "equityStake":"",
    "acquired":"Transposagen",
    "acquiror":"JNJ",
    "scope":"WW",
    "txArea":" Oncology (CAR-T)",
    "stage":"Discovery",
    "comment":"Platform license",
    "detail":""
  },
  {
    "dateAnnounced":"12/2/2014",
    "currency":"$",
    "headline":"310",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Sanofi (R&D)",
    "acquiror":"Evotec",
    "scope":"WW",
    "txArea":" R&D",
    "stage":"Discovery",
    "comment":"Research alliance (out-sourcing)",
    "detail":""
  },
  {
    "dateAnnounced":"12/2/2014",
    "currency":"$",
    "headline":"455",
    "upfront":"47",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"GeNeuro",
    "acquiror":"Servier",
    "scope":"WW",
    "txArea":" CNS (MS)",
    "stage":"Phase II",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"12/5/2014",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Opus Bio",
    "acquiror":"Juno Therapeutics",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase I",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"12/8/2014",
    "currency":"$",
    "headline":"280",
    "upfront":"20",
    "ms":"260",
    "equityStake":"",
    "acquired":"Spark Therapeutics",
    "acquiror":"Pfizer",
    "scope":"WW",
    "txArea":" Gene therapy",
    "stage":"Pre-clinical",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"12/15/2014",
    "currency":"$",
    "headline":"570",
    "upfront":"295",
    "ms":"275",
    "equityStake":"",
    "acquired":"Opko Health",
    "acquiror":"Pfizer",
    "scope":"WW",
    "txArea":" Growth Hormone",
    "stage":"Phase III",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"12/18/2014",
    "currency":"$",
    "headline":"175",
    "upfront":"ND",
    "ms":"ND",
    "equityStake":"",
    "acquired":"Xencor",
    "acquiror":"Novo Nordisk",
    "scope":"WW",
    "txArea":" Antibody tech - indication ND",
    "stage":"Discovery",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"12/22/2014",
    "currency":"$",
    "headline":"700",
    "upfront":"125",
    "ms":"MS+RoS",
    "equityStake":"Y ($75m)",
    "acquired":"MacroGenics",
    "acquiror":"J&J",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Preclinical",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"12/23/2014",
    "currency":"$",
    "headline":"77.5+",
    "upfront":"78",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Ariad",
    "acquiror":"Otsuka",
    "scope":"Asia",
    "txArea":" Oncology",
    "stage":"Approved/Phase III",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"12/23/2014",
    "currency":"$",
    "headline":"125+",
    "upfront":"ND",
    "ms":"125",
    "equityStake":"",
    "acquired":"Sevion Therapeutics",
    "acquiror":"J&J",
    "scope":"WW",
    "txArea":" Antibodies",
    "stage":"Discovery",
    "comment":"Platform license",
    "detail":""
  },
  {
    "dateAnnounced":"12/23/2014",
    "currency":"$",
    "headline":"335",
    "upfront":"5",
    "ms":"330",
    "equityStake":"",
    "acquired":"CureTech",
    "acquiror":"Medivation",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase II",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"12/23/2014",
    "currency":"$",
    "headline":"675",
    "upfront":"115",
    "ms":"600",
    "equityStake":"Y ($10m)",
    "acquired":"Cytokinetics",
    "acquiror":"Astellas",
    "scope":"WW",
    "txArea":" Muscular Diseases",
    "stage":"Phase II",
    "comment":"Research collaboration - extension",
    "detail":""
  },
  {
    "dateAnnounced":"1/5/2015",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"California Institue for Biomedical Research",
    "acquiror":"Bristol Myers",
    "scope":"WW",
    "txArea":" Fibrosis",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"1/5/2015",
    "currency":"$",
    "headline":"1000+",
    "upfront":"60",
    "ms":"",
    "equityStake":"",
    "acquired":"Kite Pharma",
    "acquiror":"Amgen",
    "scope":"WW",
    "txArea":" Oncology (CAR-T)",
    "stage":"Discovery",
    "comment":"Platform license/ Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"1/5/2015",
    "currency":"$",
    "headline":"835",
    "upfront":"35",
    "ms":"800",
    "equityStake":"",
    "acquired":"Isis Pharma",
    "acquiror":"J&J",
    "scope":"WW",
    "txArea":" GI (mRNA)",
    "stage":"Discovery",
    "comment":"Platform license",
    "detail":""
  },
  {
    "dateAnnounced":"1/6/2015",
    "currency":"$",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Vectura",
    "acquiror":"J&J",
    "scope":"WW",
    "txArea":" Respiratory disease",
    "stage":"Phase II",
    "comment":"Platform license (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"1/6/2015",
    "currency":"$",
    "headline":"60",
    "upfront":"10",
    "ms":"50",
    "equityStake":"",
    "acquired":"23andMe",
    "acquiror":"Roche",
    "scope":"WW",
    "txArea":" Genomics (Parkinsons')",
    "stage":"Discovery",
    "comment":"Data license",
    "detail":""
  },
  {
    "dateAnnounced":"1/6/2015",
    "currency":"$",
    "headline":"522",
    "upfront":"ND",
    "ms":"522",
    "equityStake":"",
    "acquired":"Cytos Biotechnology AG",
    "acquiror":"OnCore",
    "scope":"WW",
    "txArea":" HBV",
    "stage":"",
    "comment":"Platform license (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"1/6/2015",
    "currency":"$",
    "headline":"470",
    "upfront":"ND",
    "ms":"ND",
    "equityStake":"",
    "acquired":"Phenex",
    "acquiror":"Gilead",
    "scope":"WW",
    "txArea":" Liver diseases",
    "stage":"Phase II",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"1/7/2015",
    "currency":"$",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Intellia Therapeutics/Caribou Biosciences",
    "acquiror":"Novartis",
    "scope":"WW",
    "txArea":" Genomics",
    "stage":"Discovery",
    "comment":"Platform licenses",
    "detail":""
  },
  {
    "dateAnnounced":"1/9/2015",
    "currency":"$",
    "headline":"410",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Agenus",
    "acquiror":"Incyte",
    "scope":"WW",
    "txArea":" Oncology (IO)",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"1/11/2015",
    "currency":"$",
    "headline":"509+",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"AC Immune",
    "acquiror":"J&J",
    "scope":"WW",
    "txArea":" Alzheimers",
    "stage":"Phase II",
    "comment":"Product license & Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"1/12/2015",
    "currency":"$",
    "headline":"300",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Mersana Therapeutics",
    "acquiror":"Takeda",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Discovery",
    "comment":"Research collaboration (Expansion of Apr-14 deal)",
    "detail":""
  },
  {
    "dateAnnounced":"1/12/2015",
    "currency":"$",
    "headline":"1,200",
    "upfront":"",
    "ms":"",
    "equityStake":"Y ($780m)",
    "acquired":"Foundation Medicine",
    "acquiror":"Roche",
    "scope":"WW",
    "txArea":" Genomics (cancer Dx)",
    "stage":"Marketed",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"1/13/2015",
    "currency":"$",
    "headline":"241",
    "upfront":"ND",
    "ms":"",
    "equityStake":"",
    "acquired":"Vedanta",
    "acquiror":"J&J",
    "scope":"WW",
    "txArea":" IBD",
    "stage":"Pre-clinical",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"1/13/2015",
    "currency":"$",
    "headline":"750",
    "upfront":"ND",
    "ms":"",
    "equityStake":"",
    "acquired":"Meiji Seika Pharma/Fedora",
    "acquiror":"Roche",
    "scope":"ex-Japan",
    "txArea":" Anti-infectives",
    "stage":"Phase I",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"1/14/2015",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Human Longevity",
    "acquiror":"Roche",
    "scope":"WW",
    "txArea":" Genomics",
    "stage":"Discovery",
    "comment":"Platform license",
    "detail":""
  },
  {
    "dateAnnounced":"1/14/2015",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"AMG 479 (Amgen)",
    "acquiror":"NantCell (P Soon-Shiong)",
    "scope":"WW",
    "txArea":" Oncology (IO)",
    "stage":"Phase III",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"1/14/2015",
    "currency":"$",
    "headline":"100",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"MD Anderson Cancer Centre",
    "acquiror":"Intrexon/Ziopharm",
    "scope":"WW",
    "txArea":" Oncology (CAR-T)",
    "stage":"Discovery",
    "comment":"Platform license (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"1/16/2015",
    "currency":"$",
    "headline":"480",
    "upfront":"20",
    "ms":"460",
    "equityStake":"",
    "acquired":"UCB",
    "acquiror":"Ever Neuro Pharma GmbH",
    "scope":"WW",
    "txArea":" Parkinson's",
    "stage":"Pre-clinical",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"1/21/2015",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Aurigene Discovery Tech (India)",
    "acquiror":"Curis",
    "scope":"WW",
    "txArea":" Cancer",
    "stage":"Phase I",
    "comment":"Product license (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"1/21/2015",
    "currency":"$",
    "headline":"ND",
    "upfront":"ND",
    "ms":"164+",
    "equityStake":"Y ($8.4m )",
    "acquired":"Zymeworks",
    "acquiror":"Celgene",
    "scope":"WW",
    "txArea":" Multiple (Antibodies)",
    "stage":"Discovery",
    "comment":"Platform license/Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"1/29/2015",
    "currency":"ND",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Wellcome/IGI/Broad Institute/ThermoFisher Scientific",
    "acquiror":"AstraZeneca",
    "scope":"WW",
    "txArea":" Gene Editing (CRISPR)",
    "stage":"Discovery",
    "comment":"Research collaborations",
    "detail":""
  },
  {
    "dateAnnounced":"1/29/2015",
    "currency":"$",
    "headline":"5",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Raffaele-Telethon Institute for Gene Therapy",
    "acquiror":"Biogen Idec",
    "scope":"WW",
    "txArea":" Gene therapy (Haemophilia A)",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"1/29/2015",
    "currency":"$",
    "headline":"75",
    "upfront":"15",
    "ms":"55",
    "equityStake":"",
    "acquired":"Immunomic Therapeutics",
    "acquiror":"Astellas",
    "scope":"Japan",
    "txArea":" Allergy",
    "stage":"Phase I",
    "comment":"Product license (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"2/2/2015",
    "currency":"$",
    "headline":"265",
    "upfront":"15",
    "ms":"265",
    "equityStake":"Y ($30m)",
    "acquired":"Theravance Biopharma",
    "acquiror":"Mylan",
    "scope":"WW",
    "txArea":" Respiratory disease",
    "stage":"Phase II",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"2/6/2015",
    "currency":"ND",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Adimab",
    "acquiror":"Sanofi",
    "scope":"WW",
    "txArea":" Antibodies",
    "stage":"Discovery",
    "comment":"Platform license",
    "detail":""
  },
  {
    "dateAnnounced":"2/11/2015",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Advaxis",
    "acquiror":"Incyte",
    "scope":"WW",
    "txArea":" Oncology (IO)",
    "stage":"Phase II",
    "comment":"Research collaboration (combo studies)",
    "detail":""
  },
  {
    "dateAnnounced":"2/11/2015",
    "currency":"$",
    "headline":"845",
    "upfront":"100",
    "ms":"745",
    "equityStake":"Y ($30m)",
    "acquired":"Voyager Therapeutics",
    "acquiror":"Sanofi",
    "scope":"WW",
    "txArea":" Gene Therapy (CNS)",
    "stage":"Phase I",
    "comment":"Product license(s)",
    "detail":""
  },
  {
    "dateAnnounced":"2/17/2015",
    "currency":"$",
    "headline":"120",
    "upfront":"30",
    "ms":"90",
    "equityStake":"",
    "acquired":"Eagle Pharmaceuticals",
    "acquiror":"Teva",
    "scope":"US",
    "txArea":" Oncology (CLL)",
    "stage":"Phase III/submitted",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"2/18/2015",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Lead Pharma Holding",
    "acquiror":"Sanofi",
    "scope":"WW",
    "txArea":" Autoimmune (RA, IBD)",
    "stage":"Phase I",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"2/20/2015",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Eli Lilly (LY2456302)",
    "acquiror":"Cerecor Inc",
    "scope":"WW",
    "txArea":" Substance Abuse/Mental Health",
    "stage":"Phase II",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"2/23/2015",
    "currency":"$",
    "headline":"339",
    "upfront":"30",
    "ms":"309",
    "equityStake":"",
    "acquired":"Rigel Pharmaceuticals",
    "acquiror":"Bristol Myers Squibb",
    "scope":"WW",
    "txArea":" Cancer",
    "stage":"Phase I",
    "comment":"Product license (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"2/23/2015",
    "currency":"$",
    "headline":"450",
    "upfront":"94",
    "ms":"$250 (R&D)",
    "equityStake":"Y ($106m - 15%)",
    "acquired":"NGM Biopharmaceuticals",
    "acquiror":"Merck&Co",
    "scope":"",
    "txArea":" Cardiometaboblic & Cancer",
    "stage":"Pre-clinical",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"2/25/2015",
    "currency":"$",
    "headline":"109",
    "upfront":"7",
    "ms":"",
    "equityStake":"",
    "acquired":"Canbex Therapeutics",
    "acquiror":"Ipsen",
    "scope":"WW",
    "txArea":" Neuromuscular",
    "stage":"Pre-clinical",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"2/25/2015",
    "currency":"$",
    "headline":"123",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Orca Pharmaceuticals (UK)",
    "acquiror":"AstraZeneca",
    "scope":"WW",
    "txArea":" Autoimmune ",
    "stage":"Pre-clinical",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"3/2/2015",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Amgen (AMG714)",
    "acquiror":"Celimmune LLC",
    "scope":"WW",
    "txArea":" Product license",
    "stage":"Phase II",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"3/2/2015",
    "currency":"$",
    "headline":"205",
    "upfront":"10",
    "ms":"195",
    "equityStake":"",
    "acquired":"Athersys",
    "acquiror":"Chugai",
    "scope":"Japan",
    "txArea":" CVD (stem cells)",
    "stage":"Phase II",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"3/3/2015",
    "currency":"$",
    "headline":"265",
    "upfront":"15",
    "ms":"250",
    "equityStake":"",
    "acquired":"Blueprinte Medicines",
    "acquiror":"Alexion",
    "scope":"WW",
    "txArea":" Rare Diseases",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"3/4/2015",
    "currency":"$",
    "headline":"975",
    "upfront":"60",
    "ms":"915",
    "equityStake":"",
    "acquired":"Bavarian Nordic",
    "acquiror":"Bristol Myers Squibb",
    "scope":"WW",
    "txArea":" Oncology",
    "stage":"Phase III",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"3/13/2015",
    "currency":"$",
    "headline":"31",
    "upfront":"1",
    "ms":"",
    "equityStake":"",
    "acquired":"Pharmaxis",
    "acquiror":"Boehringer Ingelheim GmbH",
    "scope":"WW",
    "txArea":" Rare Disease (NASH)",
    "stage":"Phase II",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"3/13/2015",
    "currency":"$",
    "headline":"110",
    "upfront":"40",
    "ms":"70",
    "equityStake":"",
    "acquired":"Eisai (EP-6438)",
    "acquiror":"Epizyme",
    "scope":"WW (ex-JPN)",
    "txArea":" Oncology",
    "stage":"Phase I/II",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"3/22/2015",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Kite Pharma",
    "acquiror":"Bluebird bio",
    "scope":"WW",
    "txArea":" Oncology/Gene-editing",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"3/30/2015",
    "currency":"$",
    "headline":"750",
    "upfront":"200",
    "ms":"500",
    "equityStake":"Y ( $25m for 2.7%) + $25m in future)",
    "acquired":"Aduro Biotech",
    "acquiror":"Novartis",
    "scope":"",
    "txArea":" Oncology (IO)",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"3/30/2015",
    "currency":"$",
    "headline":"941",
    "upfront":"115",
    "ms":"826",
    "equityStake":"",
    "acquired":"Intrexon",
    "acquiror":"Merck KGaA",
    "scope":"",
    "txArea":" Oncology (IO)",
    "stage":"Preclinical",
    "comment":"Research collaboration (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"4/17/2015",
    "currency":"$",
    "headline":"270",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Kyoto University",
    "acquiror":"Takeda",
    "scope":"Japan",
    "txArea":" Stem Cell Tx",
    "stage":"Preclinical",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"4/20/2015",
    "currency":"$",
    "headline":"555",
    "upfront":"25",
    "ms":"530",
    "equityStake":"",
    "acquired":"Curadev Pharma",
    "acquiror":"Roche",
    "scope":"WW",
    "txArea":" Oncology (IO)",
    "stage":"Preclinical",
    "comment":"Licensing deal",
    "detail":""
  },
  {
    "dateAnnounced":"4/22/2015",
    "currency":"",
    "headline":"ND",
    "upfront":"",
    "ms":"",
    "equityStake":"Yes",
    "acquired":"Potenza ",
    "acquiror":"Astellas",
    "scope":"WW",
    "txArea":" Oncology (IO)",
    "stage":"Discovery",
    "comment":"Research collaboration (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"5/19/2015",
    "currency":"$",
    "headline":"1,100",
    "upfront":"na",
    "ms":"905",
    "equityStake":"Y ($225m)",
    "acquired":"Achillion Pharmaceuticals",
    "acquiror":"J&J",
    "scope":"WW",
    "txArea":" Hepatitis C",
    "stage":"Phase II",
    "comment":"Platform license",
    "detail":""
  },
  {
    "dateAnnounced":"5/27/2015",
    "currency":"",
    "headline":"725",
    "upfront":"25",
    "ms":"700",
    "equityStake":"",
    "acquired":"Editas Medicine",
    "acquiror":"Juno Therapeutics",
    "scope":"WW",
    "txArea":" Oncology ",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"6/4/2015",
    "currency":"$",
    "headline":"1,200",
    "upfront":"80",
    "ms":"1100",
    "equityStake":"",
    "acquired":"Parion Sciences",
    "acquiror":"Vertex",
    "scope":"WW",
    "txArea":" Cystic Fibrosis",
    "stage":"Phase II",
    "comment":"R&D collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"6/8/2015",
    "currency":"$",
    "headline":"645",
    "upfront":"25+5",
    "ms":"615+",
    "equityStake":"",
    "acquired":"Unum Therapeutics",
    "acquiror":"Seattle Genetics",
    "scope":"WW",
    "txArea":" Oncology (IO)",
    "stage":"Phase I",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"6/9/2015",
    "currency":"$",
    "headline":"106",
    "upfront":"83",
    "ms":"22.5",
    "equityStake":"Yes",
    "acquired":"Lycera Corp",
    "acquiror":"Celgene",
    "scope":"WW",
    "txArea":" Autoimmune (IBD)",
    "stage":"Phase I",
    "comment":"Product license + Option to acquire",
    "detail":""
  },
  {
    "dateAnnounced":"6/15/2015",
    "currency":"$",
    "headline":"364",
    "upfront":"15",
    "ms":"349",
    "equityStake":"",
    "acquired":"Almac Discovery",
    "acquiror":"Roche",
    "scope":"WW",
    "txArea":" ND",
    "stage":"Preclinical",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"6/15/2015",
    "currency":"$",
    "headline":"130",
    "upfront":"40",
    "ms":"90",
    "equityStake":"",
    "acquired":"Taiho",
    "acquiror":"Servier",
    "scope":"EU",
    "txArea":" Oncology",
    "stage":"Under Review",
    "comment":"Product license (exclusive)",
    "detail":""
  },
  {
    "dateAnnounced":"6/17/2015",
    "currency":"$",
    "headline":"130",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Taiho (TAS-102)",
    "acquiror":"Servier",
    "scope":"EU",
    "txArea":" Oncology",
    "stage":"Under review",
    "comment":"Product license",
    "detail":""
  },
  {
    "dateAnnounced":"6/29/2015",
    "currency":"$",
    "headline":"1,000",
    "upfront":"150+eq inv",
    "ms":"RoS",
    "equityStake":"Yes",
    "acquired":"Juno Therapeutics",
    "acquiror":"Celgene",
    "scope":"WW",
    "txArea":" Oncology ",
    "stage":"Discovery",
    "comment":"Research collaboration",
    "detail":""
  },
  {
    "dateAnnounced":"6/26/3013",
    "currency":"$",
    "headline":"818",
    "upfront":"92",
    "ms":"",
    "equityStake":"Yes",
    "acquired":"Morphosys",
    "acquiror":"Celgene",
    "scope":"WW",
    "txArea":"Oncology",
    "stage":"Phase I/Iia",
    "comment":"Product license (co-develop & commercialise)",
    "detail":""
  },
  {
    "dateAnnounced":"2/24/3014",
    "currency":"$",
    "headline":"ND",
    "upfront":"16",
    "ms":"MS+RoS",
    "equityStake":"",
    "acquired":"Discuva",
    "acquiror":"Roche",
    "scope":"WW",
    "txArea":"Anti-infectives",
    "stage":"Discovery",
    "comment":"Platform license (discovery & development)",
    "detail":""
  },
  {
    "dateAnnounced":" 2012",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Astrazeneca and Ardelyx",
    "acquiror":"",
    "scope":"",
    "txArea":"",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":" 2012",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Servier and MacroGenics (DART Tech)",
    "acquiror":"",
    "scope":"",
    "txArea":"",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"2012",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Bristol-Myers Squibb and AstraZeneca",
    "acquiror":"",
    "scope":"",
    "txArea":"",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"2012",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Xenon and Genentech",
    "acquiror":"",
    "scope":"",
    "txArea":"",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"2012",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Threshold Pharmaceuticals and Merck KGaA",
    "acquiror":"",
    "scope":"",
    "txArea":"",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"2012",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Celgene and Inhibrx",
    "acquiror":"",
    "scope":"",
    "txArea":"",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"2012",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Thrombogenics and Merck KGaA",
    "acquiror":"",
    "scope":"",
    "txArea":"",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"2012",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Enanta and Novartis",
    "acquiror":"",
    "scope":"",
    "txArea":"",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"2012",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"AC Immune and Genentech",
    "acquiror":"",
    "scope":"",
    "txArea":"",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"2012",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Bionomics and Ironwood Pharmaceuticals",
    "acquiror":"",
    "scope":"",
    "txArea":"",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"2012",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Virobay and Leo Pharma",
    "acquiror":"",
    "scope":"",
    "txArea":"",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"2012",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Angiochem and GlaxoSmithKline",
    "acquiror":"",
    "scope":"",
    "txArea":"",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"2012",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Isis Pharmaceuticals and Biogen Idec",
    "acquiror":"",
    "scope":"",
    "txArea":"",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"2012",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Isis Pharmaceuticals and Biogen Idec, Take Two",
    "acquiror":"",
    "scope":"",
    "txArea":"",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"2013",
    "currency":"$",
    "headline":"",
    "upfront":"3250",
    "ms":"",
    "equityStake":"",
    "acquired":"Elan",
    "acquiror":"Biogen",
    "scope":"WW",
    "txArea":"",
    "stage":"",
    "comment":"Product license (Tysabri)",
    "detail":""
  },
  {
    "dateAnnounced":"2013",
    "currency":"$",
    "headline":"",
    "upfront":"518",
    "ms":"",
    "equityStake":"",
    "acquired":"Fosun International",
    "acquiror":"Stellas LifeSciences Group",
    "scope":"",
    "txArea":"Oncology + Diabetes",
    "stage":"Pre-clinical",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"2013",
    "currency":"$",
    "headline":"",
    "upfront":"350",
    "ms":"",
    "equityStake":"",
    "acquired":"FibroGen",
    "acquiror":"Astrazeneca",
    "scope":"",
    "txArea":"",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"2013",
    "currency":"$",
    "headline":"",
    "upfront":"240",
    "ms":"",
    "equityStake":"",
    "acquired":"Moderna Therapeutics",
    "acquiror":"Astrazeneca",
    "scope":"",
    "txArea":"Oncology",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"2013",
    "currency":"$",
    "headline":"",
    "upfront":"155",
    "ms":"",
    "equityStake":"",
    "acquired":"OncoMed",
    "acquiror":"Celgene",
    "scope":"",
    "txArea":"Oncology",
    "stage":"Phase II",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"2013",
    "currency":"$",
    "headline":"1780",
    "upfront":"200",
    "ms":"",
    "equityStake":"",
    "acquired":"Pfizer",
    "acquiror":"Eli Lilly",
    "scope":"",
    "txArea":"",
    "stage":"Phase III",
    "comment":"Co-development",
    "detail":""
  },
  {
    "dateAnnounced":"2013",
    "currency":"$",
    "headline":"945",
    "upfront":"200",
    "ms":"",
    "equityStake":"",
    "acquired":"Forma Therapeutics",
    "acquiror":"Celgene",
    "scope":"",
    "txArea":"",
    "stage":"Discovery",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"2013",
    "currency":"$",
    "headline":"1700",
    "upfront":"100",
    "ms":"",
    "equityStake":"",
    "acquired":"Celgene/Acetylon",
    "acquiror":"",
    "scope":"",
    "txArea":"",
    "stage":"Phase Ib",
    "comment":"Collaboration and optio to acquire",
    "detail":""
  },
  {
    "dateAnnounced":"2013",
    "currency":"$",
    "headline":"1130",
    "upfront":"1130",
    "ms":"",
    "equityStake":"",
    "acquired":"GSK",
    "acquiror":"Aspen",
    "scope":"",
    "txArea":"",
    "stage":"Marketed",
    "comment":"Acquisition of assets",
    "detail":"MOVE TO M&A TAB"
  },
  {
    "dateAnnounced":"2013",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"",
    "acquiror":"",
    "scope":"",
    "txArea":"",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"2014",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"",
    "acquiror":"",
    "scope":"",
    "txArea":"",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"Aug-13",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Bionomics",
    "acquiror":"Merck",
    "scope":"",
    "txArea":"Neuropathic pain",
    "stage":"",
    "comment":"",
    "detail":""
  },
  {
    "dateAnnounced":"Oct 2012",
    "currency":"",
    "headline":"",
    "upfront":"",
    "ms":"",
    "equityStake":"",
    "acquired":"Merck & CO and Ablynx",
    "acquiror":"",
    "scope":"",
    "txArea":"",
    "stage":"",
    "comment":"",
    "detail":""
  }
]
